FDA limits Johnson and Johnson COVID shot due to rare blood-clotting syndrome

Though the U.S. is starting to get back to a semblance of normalcy more than two years after COVID-19 became part of life, vaccine manufacturers are still competing to dominate the market and the general debate over the coronavirus vaccine continues, with validity to both skeptics’ and advocates’ arguments. Most recently, because of the risk … Continue reading FDA limits Johnson and Johnson COVID shot due to rare blood-clotting syndrome